This Week on NeurologyLive — June 7, 2021


Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!

Today, Monday, June 7, the FDA is set to make a decision on the controversial and investigational Alzheimer disease treatment aducanumab after its 2-year journey to the regulatory agency. NeurologyLive is preparing to cover this news as soon as it happens and will continue to discuss the implications of the FDA decision with experts in the care of Alzheimer and investigators involved in the clinical development of the Biogen agent throughout the week.

To catch up on all of our aducanumab coverage, click here.

The American Headache Society's 63rd Annual Scientific Meeting may have wrapped up on Sunday, but NeurologyLive's coverage of the meeting will extend through this week and beyond. It includes key updates from the virtual conference floor, including the latest data on novel therapeutic approaches to migraine care, recaps of study presentations, and in-depth interviews with experts and opinion leaders who attended the meeting.

To catch up on the latest from the AHS Annual Meeting, click here.

The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, also goes live on Wednesday, June 9. This week features a conversation with Andrew Blumenfeld, MD, director of the Headache Center of Southern California. He and his colleagues conducted a study that provided real-world evidence for control of chronic migraine in patients who received CGRP monoclonal antibody added to onabotulinumtoxinA. He will break down the study in detail, including the significance of his findings, complexities in conducting layered treatment approaches, and other aspects of research that may be on the horizon.

To check out the prior NeuroVoices conversations, click here.

The next episode of our free monthly webinar series, "The Ever-Changing Face of Multiple Sclerosis," put on in partnership with the Consortium of Multiple Sclerosis Centers, is coming up! This episode is set to broadcast live on Wednesday, June 16, at 7:00 pm. This time, you'll join Ahmed Obeidat, MD, PhD; Anne Cross, MD, and Gloria von Geldern, MD, for a detailed discussion on the evolution of diagnosis and treating multiple sclerosis care during a pandemic.

To register for the broadcast for free, click here.

Throughout the week, the new NeurologyLive Insights series, "Use of High-Efficacy Therapies for Treatment of Relapsing Multiple Sclerosis," will air additional episodes featuring perspectives from Enrique Alvarez, MD, PhD and Lawrence Steinman, MD. The series includes the pair's opinions on key factors to consider when using high-efficacy therapies in relapsing multiple sclerosis, as well as an overview of emerging data for potential new treatment options.

To catch up on the series, click here.

The NeurologyLive Peer Exchange series, "Redefining Treatment Outcomes in Dravet Syndrome," has launched! The series, which offers recommendations for the diagnosis, treatment, and management of patients with Dravet syndrome, features Joseph Sullivan, MD; Trevor J. Resnick, MD; Elizabeth A. Thiele MD, PhD; and Elaine C. Wirrell, MD. Thus far, the group has provided an overview of Dravet syndrome and explored why the early diagnosis is vital to care, which patient profiles should be noted for ordering genetic testing, and what to do with those results.

To catch up on the series, click here.

This week the MJH Life Sciences Medical World News streaming channel is launching Season 2, which will begin airing fresh new episodes of your favorite shows on Monday, June 7. This week, NeurologyLive will be contributing to Deep Dive, which will air on Tuesday, June 8. This episode will feature a conversation we had with Robert Zivadanov, MD, PhD, the director of the Buffalo Neuroimaging Analysis Center, about his investigations into a novel biomarker for progressive multiple sclerosis.

To catch up and check out what's on the Medical World News channel now, click here.


If you missed your chance to see the May broadcast of our free webinar series, "The Ever-Changing Face of Multiple Sclerosis," put on in partnership with the Consortium of Multiple Sclerosis Centers, don't fret! You can join Ahmed Obeidat, MD, PhD; Mitch Freedman, MD; and Suma Shah, MD, and others as they discuss the evolution of therapeutics for the treatment of multiple sclerosis. Additionally, you can register for the live broadcast of the third installment on June 16, 2021, for a detailed discussion on the evolution of diagnosis and treating multiple sclerosis care during a pandemic featuring Obeidat; Anne Cross, MD; and Gloria von Geldern, MD.

To register for the next broadcast for free, click here.

To view the enduring version of either of the first 2 programs, click here for our Future Leaders in Neurology section.

Related Videos
Sanjay R. Patel, MD, MS
Patricia K. Coyle, MD
Video 2 - 5 KOLs are featured in "Natural History of Spinal Muscular Atrophy"
Video 1 - 5 KOLs are featured in "Clinical Features and Phenotypes of Spinal Muscular Atrophy"
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
© 2024 MJH Life Sciences

All rights reserved.